TY - JOUR
T1 - Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state
AU - de Vries, I. Jolanda M.
AU - Krooshoop, Daniëlle J. E. B.
AU - Scharenborg, Nicole M.
AU - Lesterhuis, W. Joost
AU - Diepstra, J. Heleen S.
AU - van Muijen, Goos N. P.
AU - Strijk, Simon P.
AU - Ruers, Theo J.
AU - Boerman, Otto C.
AU - Oyen, Wim J. G.
AU - Adema, Gosse J.
AU - Punt, Cornelis J. A.
AU - Figdor, Carl G.
PY - 2003
Y1 - 2003
N2 - Dendritic cells are the professional antigen-presenting cells of the immune system. To induce an effective immune response, these cells should not only express high levels of MHC and costimulatory molecules but also migrate into the lymph nodes to interact with naïve T cells. Here, we demonstrate that in vitro-generated mature, but not immature dendritic cells, efficiently migrate into the T-cell areas of lymph nodes of melanoma patients. This difference is confirmed by in vitro studies, in which immature dendritic cells are strongly adherent, whereas mature dendritic cells remain highly motile. Our present findings demonstrate that the ability of dendritic cells to mount a proper immune response correlates with their ability to migrate both in vitro and in vivo
AB - Dendritic cells are the professional antigen-presenting cells of the immune system. To induce an effective immune response, these cells should not only express high levels of MHC and costimulatory molecules but also migrate into the lymph nodes to interact with naïve T cells. Here, we demonstrate that in vitro-generated mature, but not immature dendritic cells, efficiently migrate into the T-cell areas of lymph nodes of melanoma patients. This difference is confirmed by in vitro studies, in which immature dendritic cells are strongly adherent, whereas mature dendritic cells remain highly motile. Our present findings demonstrate that the ability of dendritic cells to mount a proper immune response correlates with their ability to migrate both in vitro and in vivo
M3 - Article
C2 - 12517769
SN - 0008-5472
VL - 63
SP - 12
EP - 17
JO - Cancer research
JF - Cancer research
IS - 1
ER -